Granahan Investment Management LLC Has $50,000 Position in Biomerica, Inc. $BMRA

Granahan Investment Management LLC lessened its holdings in shares of Biomerica, Inc. (NASDAQ:BMRA) by 86.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,968 shares of the company’s stock after selling 570,799 shares during the quarter. Granahan Investment Management LLC owned 3.46% of Biomerica worth $50,000 as of its most recent SEC filing.

Separately, Bulltick Wealth Management LLC acquired a new position in shares of Biomerica during the first quarter valued at about $78,000. Institutional investors and hedge funds own 22.28% of the company’s stock.

Biomerica Price Performance

NASDAQ:BMRA opened at $2.75 on Friday. The firm has a 50-day moving average of $3.25 and a 200-day moving average of $3.85. The company has a market cap of $7.76 million, a PE ratio of -1.19 and a beta of 0.35. Biomerica, Inc. has a one year low of $2.08 and a one year high of $10.16.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.